- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech High Growth Potential Companies
Indian Pharmaceuticals & Biotech High Growth Potential Companies
Results
40
Companies with a Future performance score of at least 3, ordered by Future performance score.
40 companies
J. B. Chemicals & Pharmaceuticals
Market Cap: ₹247.7b
Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
506943
₹1,627.15
7D
5.6%
1Y
-9.4%
Glenmark Pharmaceuticals
Market Cap: ₹388.5b
Develops, manufactures, and sells generics, specialty products, and OTC pharmaceutical products in India, North America, Latin America, Europe, and internationally.
GLENMARK
₹1,356.80
7D
-1.4%
1Y
28.0%
Sanofi India
Market Cap: ₹142.9b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹6,205.05
7D
2.6%
1Y
-26.1%
Syngene International
Market Cap: ₹292.6b
A contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.
SYNGENE
₹729.15
7D
5.4%
1Y
2.6%